MCNEIL PHARMACEUTICAL,DIV. OF MCNEIL LABS INC. -- HALDOL BRAND HALOPERIDOL TABLETS - 5 MG -- 6505-00-480-7255
===================== Product Identification =====================
Product ID:HALDOL BRAND HALOPERIDOL TABLETS - 5 MG
MSDS Date:11/21/1985
FSC:6505
NIIN:00-480-7255
MSDS Number: BDZWN
=== Responsible Party ===
Company Name:MCNEIL PHARMACEUTICAL,DIV. OF MCNEIL LABS INC.
Address:WELSH & MCKEAN ROADS
City:SPRING HOUSE
State:PA
ZIP:19477-0776
Country:US
Info Phone Num:215-628-5000
Emergency Phone Num:215-628-5000
Preparer's Name:BRIAN E. REYNOLDS,PH.D.
CAGE:04501
=== Contractor Identification ===
Company Name:MCNEIL PHARMACEUTICAL DIVISION OF MCNEIL LAB INC
Address:WELSH RD
Box:City:SPRING HOUSE
State:PA
ZIP:19477
Country:US
Phone:215-628-5000
CAGE:04501
============= Composition/Information on Ingredients =============
Ingred Name:HALOPERIDOL <
4-(4-(P-CHLOROPHENYL)-4-HYDROXYPIPERIDINO)-4-FLUORO-BUTYROPHENONE >
CAS:52-86-8
RTECS #:EU1575000
Fraction by Wt: 0.4-8%
Ingred Name:STARCH
CAS:9005-25-8
RTECS #:GM5090000
Fraction by Wt: 13-20%
OSHA PEL:15 MG/M3 TDUST
ACGIH TLV:10 MG/M3; 9192
===================== Hazards Identification =====================
LD50 LC50 Mixture:93 TO 163 MG/KG ORAL RATS (ACTIVE INGRED
Routes of Entry: Inhalation:NO Skin:NO Ingestion:YES
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:MANUFACTURER LISTS A SLIGHT HEALTH
HAZARD, WITH SLIGHT ACUTE TOXICITY TO THE EYES.
Effects of Overexposure:TRANSFER OF MATERIAL FROM FINGERS TO EYE IS THE
ONLY HAZARD LIKELY TO OCCUR DURING EXPECTED HANDLING AND/OR USE.
Medical Cond Aggravated by Exposure:SEE BOX INSERT FOR CAUTIONS.
======================= First Aid Measures =======================
First Aid:FLUSH EYES WITH LARGE AMOUNTS OF WATER. SEE A PHYSICIAN. SEE
INSERT PACKED IN BOX FOR FURTHER INSTRUCTIONS.
===================== Fire Fighting Measures =====================
Flash Point:NONE
Extinguishing Media:USE MEDIA SUITABLE FOR SURROUNDING FIRE.
Fire Fighting Procedures:USE NORMAL FIRE FIGHTING PROCEDURES.
Unusual Fire/Explosion Hazard:NONE
================== Accidental Release Measures ==================
Spill Release Procedures:SWEEP OR VACUUM INTO A CLOSED WASTE CONTAINER.
Neutralizing Agent:NONE
====================== Handling and Storage ======================
Handling and Storage Precautions:THIS PRODUCT IS A PRESCRIPTION DRUG.
HANDLE AND STORE APPROPRIATELY.
Other Precautions:REFER TO BOX INSERT BEFORE USING OR HANDLING.
============= Exposure Controls/Personal Protection =============
Respiratory Protection:NONE NEEDED
Ventilation:NORMAL ROOM VENTILATION. WHEN HANDLING LARGE AMOUNTS , USE
LOCAL EXHAUST TO COLLECT ANY DUST GENERATED.
Protective Gloves:NONE NEEDED
Eye Protection:NONE REQUIRED
Other Protective Equipment:NO SPECIAL PROTECTION REQUIRED.
Work Hygienic Practices:WASH THOROUGHLY AFTER HANDLING. USE NORMAL
PRESCRIPTION DRUG HANDLING HYGIENIC PROCEDURES.
Supplemental Safety and Health
================== Physical/Chemical Properties ==================
HCC:N1
Appearance and Odor:TABLETS; MAY BE WHITE,YELLOW,PINK,GREEN,AQUA,OR
SALMON. MILD ODOR OF ANISETTE.
================= Stability and Reactivity Data =================
Stability Indicator/Materials to Avoid:YES
NONE KNOWN
Stability Condition to Avoid:NONE KNOWN
Hazardous Decomposition Products:HMIS: EXCEPT CARBON DIOXIDE AND CARBON
MONOXIDE IN EVENT OF FIRE.
==================== Disposal Considerations ====================
Waste Disposal Methods:MATERIAL IS NOT A HAZARDOUS WASTE. IT MAY BE
DISPOSED OF AS NORMAL SOLID WASTE I/A/W FEDERAL,STATE,LOCAL
REGULATIONS.
Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.